To help keep our community authentic, we're showing information about accounts on Linktree.
Tim McFarlane Studio has been a member of Linktree for 5 years and joined in July 2020. The social media accounts linked to from Tim McFarlane Studio are: Instagram, Email. Besides social media accounts, TimMcFarlane has populated their site with Canvas Rebel: Meet Tim McFarlane, Interview on ArtShow with Craig Stover, Works Available: Phillip Slein Gallery, Artist Representation: Bridgette Mayer Gallery, Tim McFarlane: Website, Photography: Daily Observations, Tomorrow’s Conversations (2020): Variable print edition, Tim McFarlane Studio: Art & Life Stirred Vigorously | Substack, Tim McFarlane Studio Newsletter | Substack, Shifting Time: African American Artists 2020-2021, Issue 03 - Passing Notes-A Journal for Artists who Write, Feature article on The Artblog: Contemporary art mingles with vintage clothing in All Night Party, Tim McFarlane — Conversations with Artists, Cultural Canvases: Episode Five - Tim McFarlane, Tim McFarlane: Abstract artist uses creativity to make stunning art pieces, Tim McFarlane: Time & The Cracks Between Things, Be Here Now…with Tim McFarlane, Tim McFarlane — LAURA SALLADE, The Truth In This Art | Tim McFarlane, Pathways for Dialogue: Artist Talk Featuring Dianne Smith & Tim McFarlane, Moderated by Nicole Moore, The Vast Parlor interview: A Couple of Things with Tim McFarlane, Conversation with TJ Walsh in the Bold Creatives Collective Facebook Group, The Bold Creatives Collective Podcast - Embracing Growth & Inspiring Reinvention featuring Tim McFarlane | RSS.com, Tim McFarlane: "Being An Artist" podcast, Creativity Is A Journey: Create! Magazine interview, Interview with Brainard Carey on Yale University radio, Instagram-Art Account, Instagram-photography: @timmcfarlanephoto, Virtual Artist Talk for All Night Party at Towson University, Tim McFarlane's Spotify Takeover for Magz FM, Deep House playlist on SoundCloud, TIM McFARLANE — GRAND IMAGE, Tim McFarlane on Artblog: Artists in the Time of Coronavirus.